C
0.971
0.02 (1.91%)
| Penutupan Terdahulu | 0.952 |
| Buka | 0.940 |
| Jumlah Dagangan | 41,254 |
| Purata Dagangan (3B) | 146,790 |
| Modal Pasaran | 53,922,048 |
| Harga / Pendapatan (P/E Ke hadapan) | 0.770 |
| Harga / Jualan (P/S) | 3.65 |
| Harga / Buku (P/B) | 1.15 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 5 Sep 2025 - 19 Sep 2025 |
| Margin Keuntungan | -66.10% |
| Margin Operasi (TTM) | -81.69% |
| EPS Cair (TTM) | -0.310 |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 1.13% |
| Nisbah Semasa (MRQ) | 10.25 |
| Aliran Tunai Operasi (OCF TTM) | -32.98 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -5.98 M |
| Pulangan Atas Aset (ROA TTM) | -12.47% |
| Pulangan Atas Ekuiti (ROE TTM) | -18.66% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Biotechnology (US) | Bercampur | Menurun |
| Biotechnology (Global) | Bercampur | Menurun | |
| Stok | Connect Biopharma Holdings Limi | Menurun | Menurun |
AISkor Stockmoo
1.8
| Konsensus Penganalisis | 1.5 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | -2.0 |
| Purata Bergerak Teknikal | 3.5 |
| Osilator Teknikal | 4.0 |
| Purata | 1.75 |
|
Connect Biopharma Holdings Ltd is a clinical-stage company focused on the discovery and development of next-generation immune modulators for the treatment of serious autoimmune diseases and inflammation. It has leveraged its expertise in the biology of T cell modulation to build a portfolio of drug candidates consisting of small molecules and antibodies targeting critical pathways of inflammation. Its pipeline includes CBP-201, CBP-307 and CBP-174. |
|
| Sektor | Healthcare |
| Industri | Biotechnology |
| % Dimiliki oleh Orang Dalam | 40.65% |
| % Dimiliki oleh Institusi | 43.97% |
Pemilikan
| Nama | Tarikh | Syer Dipegang |
|---|---|---|
| Callan Capital, Llc | 31 Mar 2025 | 80,000 |
| Geowealth Management, Llc | 31 Mar 2025 | 0 |
| Julat 52 Minggu | ||
| Median | 7.00 (621.28%) | |
| Jumlah | 1 Beli | |
| Syarikat | Tarikh | Harga Sasaran | Panggilan | Harga @ Panggilan |
|---|---|---|---|---|
| HC Wainwright & Co. | 12 Jun 2025 | 7.00 (621.28%) | Beli | 0.850 |
Tiada data dalam julat masa ini.
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2025 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |